Evidence map›Paper›PMID 22692127›Full record

ArticleThe EMBO journal2012

Impairment of GABAB receptor dimer by endogenous 14-3-3ζ in chronic pain conditions.

Sophie Laffray, Rabia Bouali-Benazzouz, Marie-Amélie Papon, Alexandre Favereaux, Yang Jiang, Tina Holm, Corentin Spriet, Pascal Desbarats, Pascal Fossat, Yves Le Feuvre and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 53 citations in OpenAlex.

  1. GABAMedComm · 2025
    Review
  2. Review
  3. The role of GABAFrontiers in endocrinology · 2023
    Review
  4. Article
  5. Neuronal G protein-gated KAmerican journal of physiology. Cell physiology · 2022
    Review
  6. GABACurrent topics in behavioral neurosciences · 2022
    Review
  7. Mechanisms and Regulation of Neuronal GABACurrent topics in behavioral neurosciences · 2022
    Review
  8. MicroRNA-330 Directs Downregulation of the GABAJournal of molecular neuroscience : MN · 2020
    Article
  9. Article
  10. Frontiers in cellular and infection microbiology · 2019
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. GABA pharmacology: the search for analgesics.Neurochemical research · 2014
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Sophie LaffrayBordeaux University, Bordeaux, France.
Rabia Bouali-Benazzouz
Marie-Amélie Papon
Alexandre Favereaux
Yang Jiang
Tina Holm
Corentin Spriet
Pascal Desbarats
Pascal Fossat
Yves Le Feuvre
Marion Decossas
Laurent Héliot
Ulo Langel
Frédéric Nagy
Marc Landry
Centre National de la Recherche Scientifique · FRInstitut Interdisciplinaire de Neuroscience · FRStockholm University · SEInstitut d'Imagerie Biomédicale · FRUniversité de Bordeaux · FRBordeaux Population Health · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the central nervous system, the inhibitory GABAB receptor is the archetype of heterodimeric G protein-coupled receptors (GPCRs). However, the regulation of GABAB dimerization, and more generally of GPCR oligomerization, remains largely unknown. We propose a novel mechanism for inhibition of GPCR activity through de-dimerization in pathological conditions. We show here that 14-3-3ζ, a GABAB1-binding protein, dissociates the GABAB heterodimer, resulting in the impairment of GABAB signalling in spinal neurons. In the dorsal spinal cord of neuropathic rats, 14-3-3ζ is overexpressed and weakens GABAB inhibition. Using anti-14-3-3ζ siRNA or competing peptides disrupts 14-3-3ζ/GABAB1 interaction and restores functional GABAB heterodimers in the dorsal horn. Importantly, both strategies greatly enhance the anti-nociceptive effect of intrathecal Baclofen in neuropathic rats. Taken together, our data provide the first example of endogenous regulation of a GPCR oligomeric state and demonstrate its functional impact on the pathophysiological process of neuropathic pain sensitization.

Indexed as

14-3-3 ProteinsAnimalsCells, CulturedChronic PainDisease Models, AnimalNeuralgiaPosterior Horn CellsProtein BindingProtein Interaction Domains and MotifsProtein MultimerizationProtein SubunitsRatsRats, TransgenicReceptors, GABA-BRNA, Small Interfering14-3-3 ProteinsProtein SubunitsReceptors, GABA-BRNA, Small Interfering

Identifiers

PMID22692127
PMCPMC3411072
OpenAlexW2098347554

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.